CN101970497B - 抗‑EpCAM抗体及其用途 - Google Patents

抗‑EpCAM抗体及其用途 Download PDF

Info

Publication number
CN101970497B
CN101970497B CN200880015767.4A CN200880015767A CN101970497B CN 101970497 B CN101970497 B CN 101970497B CN 200880015767 A CN200880015767 A CN 200880015767A CN 101970497 B CN101970497 B CN 101970497B
Authority
CN
China
Prior art keywords
antibody
epcam
seq
fragment
antibody fragment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN200880015767.4A
Other languages
English (en)
Chinese (zh)
Other versions
CN101970497A (zh
Inventor
A·M·安娜斯塔斯
F·派特隆泽里
R·德桑提斯
S·阿尔波提
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Alfa Pharmaceutical Co
Original Assignee
Sigma Tau Industrie Farmaceutiche Riunite SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sigma Tau Industrie Farmaceutiche Riunite SpA filed Critical Sigma Tau Industrie Farmaceutiche Riunite SpA
Publication of CN101970497A publication Critical patent/CN101970497A/zh
Application granted granted Critical
Publication of CN101970497B publication Critical patent/CN101970497B/zh
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A61K39/39533—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals
    • A61K39/39558—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals against tumor tissues, cells, antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
    • C07K2317/77—Internalization into the cell

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Cell Biology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Biomedical Technology (AREA)
  • Oncology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
CN200880015767.4A 2007-04-04 2008-04-02 抗‑EpCAM抗体及其用途 Expired - Fee Related CN101970497B (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP07105628.7 2007-04-04
EP07105628 2007-04-04
PCT/EP2008/053913 WO2008122551A2 (en) 2007-04-04 2008-04-02 Anti-epcam antibody and uses thereof

Publications (2)

Publication Number Publication Date
CN101970497A CN101970497A (zh) 2011-02-09
CN101970497B true CN101970497B (zh) 2017-05-10

Family

ID=38458122

Family Applications (1)

Application Number Title Priority Date Filing Date
CN200880015767.4A Expired - Fee Related CN101970497B (zh) 2007-04-04 2008-04-02 抗‑EpCAM抗体及其用途

Country Status (21)

Country Link
US (1) US8318911B2 (enExample)
EP (1) EP2142570B1 (enExample)
JP (1) JP5631733B2 (enExample)
KR (1) KR101683884B1 (enExample)
CN (1) CN101970497B (enExample)
AT (1) ATE512988T1 (enExample)
AU (1) AU2008235566B2 (enExample)
BR (1) BRPI0810096A8 (enExample)
CA (1) CA2682296C (enExample)
CY (1) CY1111819T1 (enExample)
DK (1) DK2142570T3 (enExample)
EA (1) EA023679B1 (enExample)
ES (1) ES2367675T3 (enExample)
HR (1) HRP20110620T1 (enExample)
IL (1) IL201196A0 (enExample)
MX (1) MX2009010444A (enExample)
PL (1) PL2142570T3 (enExample)
PT (1) PT2142570E (enExample)
RS (1) RS52040B (enExample)
SI (1) SI2142570T1 (enExample)
WO (1) WO2008122551A2 (enExample)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004068110A2 (en) 2003-01-24 2004-08-12 University Of Utah Methods of predicting mortality risk by determining telomere length
CA2748265C (en) 2008-12-22 2018-04-03 University Of Utah Research Foundation Monochrome multiplex quantitative pcr
GB0909904D0 (en) * 2009-06-09 2009-07-22 Affitech As Product
WO2012123755A1 (en) 2011-03-17 2012-09-20 The University Of Birmingham Re-directed immunotherapy
JP6400470B2 (ja) * 2011-05-16 2018-10-03 ジェネロン（シャンハイ）コーポレイション リミテッド 多重特異性Ｆａｂ融合タンパク質および使用法
CN103998932B (zh) * 2011-06-29 2017-06-06 中央研究院 使用表面涂层对生物物质的捕获、纯化和释放
WO2013131001A1 (en) * 2012-03-02 2013-09-06 Academia Sinica ANTI-EPITHELIAL CELL ADHESION MOLECULE (EpCAM) ANTIBODIES AND METHODS OF USE THEREOF
US9494500B2 (en) 2012-10-29 2016-11-15 Academia Sinica Collection and concentration system for biologic substance of interest and use thereof
CA2912216A1 (en) 2013-05-22 2014-11-27 Telomere Diagnostics, Inc. Measures of short telomere abundance
CN106662514A (zh) 2014-04-01 2017-05-10 中央研究院 用于癌症诊断及预后的方法和系统
CN105381824B (zh) 2014-08-26 2019-04-23 中央研究院 收集器架构布局设计
WO2016108954A1 (en) 2014-12-30 2016-07-07 Telomere Diagnostics, Inc. Multiplex quantitative pcr
EP3328897A1 (en) 2015-07-31 2018-06-06 Sutro Biopharma, Inc. ANTI-EpCAM ANTIBODIES, COMPOSITIONS COMPRISING ANTI-EpCAM ANTIBODIES AND METHODS OF MAKING AND USING ANTI-EPCAM ANTIBODIES
US10107726B2 (en) 2016-03-16 2018-10-23 Cellmax, Ltd. Collection of suspended cells using a transferable membrane
CN109195990A (zh) * 2016-03-30 2019-01-11 Musc研究发展基金会 通过靶向糖蛋白a重复优势蛋白(garp)治疗和诊断癌症以及单独或联合提供有效免疫疗法的方法
CN110035768A (zh) 2016-07-26 2019-07-19 泰莎治疗私人有限公司 嵌合抗原受体
WO2020018964A1 (en) 2018-07-20 2020-01-23 Fred Hutchinson Cancer Research Center Compositions and methods for controlled expression of antigen-specific receptors
CN112867735B (zh) 2018-09-07 2025-05-09 埃泰美德(香港)有限公司 双特异性抗原结合蛋白及其用途
AU2019402097A1 (en) 2018-12-17 2021-06-10 Revitope Limited Twin immune cell engager
TW202039582A (zh) * 2019-04-22 2020-11-01 大陸商江蘇恆瑞醫藥股份有限公司 抗ＥｐＣＡＭ抗體及其應用
CA3143039A1 (en) 2019-06-11 2020-12-17 Bioatla, Inc. Conditionally active anti-epcam antibodies, antibody fragments, their immunoconjugates and uses thereof
CN110950959B (zh) * 2020-02-25 2020-07-03 和铂医药(上海)有限责任公司 靶向EpCAM的抗体及其制备和应用
CN112094350B (zh) * 2020-06-01 2024-01-05 普众发现医药科技(上海)有限公司 可应用于肿瘤细胞捕获的小鼠抗细胞表面糖蛋白cd326的单克隆抗体
US20230357427A1 (en) * 2020-08-19 2023-11-09 Shanghai Immunohead Biotechnology Co., Ltd Humanized antibody, chimeric antigen receptor, nucleic acid, vector, cell and use

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1976951A (zh) * 2004-02-13 2007-06-06 米克罗麦特股份公司 抗EpCAM免疫球蛋白

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4675187A (en) 1983-05-16 1987-06-23 Bristol-Myers Company BBM-1675, a new antibiotic complex
US5525338A (en) 1992-08-21 1996-06-11 Immunomedics, Inc. Detection and therapy of lesions with biotin/avidin conjugates
IT1245748B (it) 1990-12-21 1994-10-14 Mini Ricerca Scient Tecnolog Preparazione includente anticorpi monoclonali biotinilati, avidina e biotina, per la diagnosi di affezioni tumorali e suo impiego
US5578287A (en) 1992-06-09 1996-11-26 Neorx Corporation Three-step pretargeting methods using improved biotin-active agent
JP3427871B2 (ja) 1996-06-24 2003-07-22 戸田工業株式会社 コバルト被着型針状磁性酸化鉄粒子粉末
ITRM20010079A1 (it) 2001-02-16 2002-08-16 Sigma Tau Ind Farmaceuti Amminoderivati della biotina e loro coniugati con chelanti macrociclici.
US7435804B2 (en) * 2004-10-19 2008-10-14 Phage Biotechnology, Inc. Method for obtaining single chain antibodies to human interferon α2b

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1976951A (zh) * 2004-02-13 2007-06-06 米克罗麦特股份公司 抗EpCAM免疫球蛋白

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
Frequent high-level expression of the immunotherapeutic target Ep-CAM in colon,stomach,prostate and lung cancers;P Went，et al;《British Journal of Cancer》;20061231;第94卷;第128-135页 *
Mab17-1A and cytokines for the treatment of patients with colorectal carcinoma;Jan-Erik Frodin,et al;《Hybridoma and Hybridomics》;20021231;第21卷(第2期);第99-101页 *
人上皮细胞黏附分子融合蛋白真核表达载体的构建_表达及初步鉴定;王春艳，等;《细胞与分子免疫学杂志》;20041231;第20卷(第6期);第765-768页 *

Also Published As

Publication number Publication date
WO2008122551A9 (en) 2009-02-05
SI2142570T1 (sl) 2012-01-31
IL201196A0 (en) 2010-05-17
EA200970923A1 (ru) 2010-04-30
PL2142570T3 (pl) 2011-11-30
JP5631733B2 (ja) 2014-11-26
CY1111819T1 (el) 2015-10-07
BRPI0810096A2 (pt) 2014-10-21
KR20100016237A (ko) 2010-02-12
HRP20110620T1 (hr) 2011-09-30
WO2008122551A2 (en) 2008-10-16
AU2008235566A1 (en) 2008-10-16
RS52040B (sr) 2012-04-30
US20100092491A1 (en) 2010-04-15
BRPI0810096A8 (pt) 2017-12-26
AU2008235566B2 (en) 2013-06-06
CA2682296C (en) 2017-02-28
DK2142570T3 (da) 2011-10-03
CN101970497A (zh) 2011-02-09
CA2682296A1 (en) 2008-10-16
ATE512988T1 (de) 2011-07-15
MX2009010444A (es) 2009-10-20
EP2142570A2 (en) 2010-01-13
EP2142570B1 (en) 2011-06-15
EA023679B1 (ru) 2016-06-30
US8318911B2 (en) 2012-11-27
ES2367675T3 (es) 2011-11-07
KR101683884B1 (ko) 2016-12-07
WO2008122551A3 (en) 2008-12-04
PT2142570E (pt) 2011-09-13
JP2010523096A (ja) 2010-07-15

Similar Documents

Publication Publication Date Title
CN101970497B (zh) 抗‑EpCAM抗体及其用途
CN111944050B (zh) 一种抗b7-h3抗体及其应用
US11155632B2 (en) Anti-CD47 monoclonal antibody and use thereof
US20190321466A1 (en) Anti-pd1 monoclonal antibody, pharmaceutical composition thereof and use thereof
CN116731179A (zh) 抗ror1抗体及其制备和使用方法
US20200255536A1 (en) Target for b-cell disorders
CN101421395A (zh) 显示cd63表面表达的细胞的细胞毒性介导
EP4032908A1 (en) Anti-pd-l1 antibody and pharmaceutical use thereof
US12344669B2 (en) Anti-CD47 monoclonal antibody and use thereof
CN111100204B (zh) 靶向cd20的抗体、其制备方法和应用
HK1148536B (en) Anti-epcam antibody and uses thereof
HK1148536A (en) Anti-epcam antibody and uses thereof
CN118184785A (zh) Cea抗体及其应用
HK40010330A (en) Anti-pd1 monoclonal antibody, pharmaceutical composition thereof and use thereof

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
REG Reference to a national code

Ref country code: HK

Ref legal event code: DE

Ref document number: 1148536

Country of ref document: HK

GR01 Patent grant
GR01 Patent grant
TR01 Transfer of patent right
TR01 Transfer of patent right

Effective date of registration: 20171204

Address after: Milan Italy

Patentee after: Alfa pharmaceutical company

Address before: Rome Italy

Patentee before: Sigma-Tau Industrie Farmaceutiche Riunite S. P. A.

REG Reference to a national code

Ref country code: HK

Ref legal event code: GR

Ref document number: 1148536

Country of ref document: HK

CF01 Termination of patent right due to non-payment of annual fee
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20170510

Termination date: 20210402